Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis
Rosa Andres Ejarque(Guy's Hospital), Paola Di Meglio(King's College London), Katarzyna Grys(King's College London), Chrysanthi Ainali(King's College London), Nick J. Reynolds(Newcastle upon Tyne Hospitals NHS Foundation Trust), Frank O. Nestlé(Guy's and St Thomas' NHS Foundation Trust), Jake Saklatvala(King's College London), Emanuele de Rinaldis(Target (United States)), Anna Chapman(Queen Elizabeth Hospital), Juliet N. Barker(King's College London), C.E.M. Griffiths(King's College London), Isabella Tosi(King's College London), Richard B. Warren(Manchester Academic Health Science Centre), Hemawtee Sreeneebus(King's College London), Catherine Smith(City College of San Francisco), Shane Solanky(King's College London), Hira Bahadur Ale(King's College London), Zeynep Catak(King's College London), Michael R. Barnes(Munich Cluster for Systems Neurology), Nick Dand(King's College London)
Cited by 2
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
|Nature Genetics|2010|1.1k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892